Lupin Ltd`s Generic Albendazole Receives Approval In US
Lupin Ltd`s Generic Albendazole Receives Approval In US
Drug firm Lupin on Thursday said it has received approval from the US health regulator to market its generic anthelmintic Albendazole tablets.
The Union government is now on an aggressive mode to scale up innovations that could help eliminate the dreaded lymphatic filariasis. The initiative is under the National Vector Borne Disease Control Programme (NVBDCP). The focus is on the new Triple Drug Therapy (IDA) which will be made available in 16 districts across 5 states namely Uttar Pradesh, Bihar, Gujarat, Karnataka, and Maharashtra to accelerate the pace of elimination of the disease. The IDA is a combination of 3 anti-filarial drugs: Ivermectin, diethylcarbamazine citrate (DEC) and albendazole.
Edenbridge Pharms`s Generic Albendazole Receives Approval in US
Zydus' Generic Albendazole Receives Approval in US
Strides Vivimed`s Generic Albendazole Receives Approval in US
New Delhi: Drug firm Strides Pharma Science Tuesday said its joint venture (JV) firm has received approval from the US health regulator for Albendazole tablets, used in the treatment of certain infections caused by tapeworm. Strides Vivimed Pte Ltd, Singapore, a 50:50 joint venture with Vivimed Labs, has received approval from the United States Food & Drug Administration (US FDA) for Albendazole tablets in the strength of 200 mg, Strides Pharma Science said in a BSE filing.
Cipla's Generic Albendazole Receives Approval in US
To improve transparency and encourage the development and submission of abbreviated new drug applicationsn(ANDAs) in markets with no competition, FDA is publishing a list of approved new drug application (NDA) drugnproducts which are off patent and off exclusivity and for which the FDA has not approved an ANDA referencingnthat NDA drug product.